87 Gastrointestinal
Hansen, T. H. (2018). Improving veterans’ access to gastroenterology clinical care. Journal of the American Academy of PAs, 31(3), 47. https://doi.org/10.1097/01.JAA.0000530296.15656.8a
Järbrink-Sehgal, M. E., Sparkman, J., Damron, A., Walker, M. M., Green, L. K., Rosen, D. G., Graham, D. Y., & El-Serag, H. E. (2020). Functional dyspepsia and duodenal eosinophil count and degranulation: A multiethnic US veteran cohort study. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-020-06689-2
Hammad, T. A., Thrift, A. P., El-Serag, H. B., & Husain, N. S. (2019). Missed opportunities for screening and surveillance of Barrett’s esophagus in veterans with esophageal adenocarcinoma. Digestive Diseases and Sciences, 64(22), 367–372. https://doi.org/10.1007/s10620-018-5336-5
Liao, W.-C., Chih-Chao, C., Ma, H., & Hsu, C.-Y. (2020). Salivary gland tumors: A clinicopathologic analysis from Taipei Veterans General Hospital. Annals of Plastic Surgery, 84(1S), S26. https://doi.org/10.1097/SAP.0000000000002178
Patil, T., Murphy, K., Woodard, L., & Lebrecht, M. (2020). Proton pump inhibitor utilization in veteran patients on combined antithrombotic therapy and validation of simplified bleeding risk score. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.2477
Psevdos, G., Ford, F. M., & Hong, S.-T. (2018). Screening US Vietnam veterans for liver fluke exposure 5 decades after the end of the war. Infectious Diseases in Clinical Practice (Baltimore, Md.), 26(4), 208–210. https://doi.org/10.1097/IPC.0000000000000611
Song, K. Y., Henn, A. J., Gravely, A. A., Mesa, H., Sultan, S., Shaheen, N. J., Shaukat, A., & Hanson, B. J. (2020). Persistent confirmed low-grade dysplasia in Barrett’s esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US veterans cohort. Diseases of the Esophagus, 33. https://doi.org/10.1093/dote/doz061
Tan, M. C., Mallepally, N., Ho, Q., Liu, Y., El-Serag, H. B., & Thrift, A. P. (2020). Dietary factors and gastric intestinal metaplasia risk among US veterans. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-020-06399-9
Tan, M. C., Mallepally, N., Liu, Y., El-Serag, H. B., & Thrift, A. P. (2020). Demographic and lifestyle risk factors for gastric intestinal metaplasia among US veterans. Official Journal of the American College of Gastroenterology | ACG, 115(3), 381–387. https://doi.org/10.14309/ajg.0000000000000498
Zhou, Q., Verne, M. L., Zhang, B., & Verne, G. N. (2018). Evidence of hypersensitivity in veterans with Gulf War Illness and gastrointestinal symptoms. The Clinical Journal of Pain, 34(10), 944–949. https://doi.org/10.1097/AJP.0000000000000611
Cirrhosis
Burroughs, T. K., Wade, J. B., Ellwood, M. S., Fagan, A., Heuman, D. M., Fuchs, M., & Bajaj, J. S. (2018). Effect of post-traumatic stress disorder on cognitive function and covert hepatic encephalopathy diagnosis in cirrhotic veterans. Digestive Diseases & Sciences, 63(2), 481–485. https://doi.org/10.1007/s10620-017-4894-2
Kaplan, D. E., Chapko, M. K., Mehta, R., Dai, F., Skanderson, M., Aytaman, A., … Taddei, T. H. (2018). Healthcare costs related to treatment of hepatocellular carcinoma among veterans with cirrhosis in the United States. Clinical Gastroenterology and Hepatology, 16(1), 106-114.e5. https://doi.org/10.1016/j.cgh.2017.07.024
Rogal, S. S., Yakovchenko, V., Gonzalez, R., Park, A., Lamorte, C., Gibson, S. P., Chartier, M., Ross, D., Comstock, E., Bajaj, J. S., & Morgan, T. R. (2020). Characterizing patient-reported outcomes in veterans with cirrhosis. Plos One, 15(9), e0238712. https://doi.org/10.1371/journal.pone.0238712
Rogal, S. S., Yakovchenko, V., Morgan, T., Bajaj, J. S., Gonzalez, R., Park, A., Beste, L., Miech, E. J., Lamorte, C., Neely, B., Gibson, S., Malone, P. S., Chartier, M., Taddei, T., Garcia-Tsao, G., Powell, B. J., Dominitz, J. A., Ross, D., & Chinman, M. J. (2020). Getting to implementation: A protocol for a hybrid iII stepped wedge cluster randomized evaluation of using data-driven implementation strategies to improve cirrhosis care for veterans. Implementation Science, 15(1), 92. https://doi.org/10.1186/s13012-020-01050-7
Tayob, N., Richardson, P., White, D. L., Xiaoying Yu, Davila, J. A., Kanwal, F., … Feng, Z. (2018). Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran’s Affairs health care system. BMC Medical Research Methodology, 18, 1–13. https://doi.org/10.1186/s12874-017-0458-6
Townsend, L., Blais, P., Huh, A., Nayak, L., Elwing, J. E., & Sayuk, G. S. (2020). Survival benefit associated with early detection of spontaneous bacterial peritonitis in veteran inpatients with cirrhotic ascites. JGH Open, 4(3), 503–506. https://doi.org/10.1002/jgh3.12290
Colorectal
Edwards, G. C., Martin, R. L., Samuels, L. R., Wyman, K., Bailey, C. E., Kiernan, C. M., Snyder, R. A., Dittus, R. S., & Roumie, C. L. (2020). Association of adherence to quality metrics with recurrence or mortality among veterans with colorectal cancer. Journal of Gastrointestinal Surgery. https://doi.org/10.1007/s11605-020-04804-2
Goldshore, M. A., Mehta, S. J., Fletcher, W., Tzanis, G., Doubeni, C. A., & Paulson, E. C. (2020). An RCT of fecal immunochemical test colorectal cancer screening in veterans without recent primary care. American Journal of Preventive Medicine, 59(1), 41–48. https://doi.org/10.1016/j.amepre.2020.02.014
Imperiale, T. F., Myers, L., Imler, T. D., Sherer, E. A., Larson, J. A., & Kahi, C. J. (2018). Outcomes in veterans with advanced colorectal adenomas. Gastroenterology, 154(6), S-769. https://doi.org/10.1016/S0016-5085(18)32663-5
Issak, A., Abdulle, F., Porter, K., & Agrawal, S. (2020). The relationship between number of comorbidities and age of colorectal cancer diagnosis in US male veteran population: A single-center experience. Gastroenterology Research, 13(2), 66–72. https://doi.org/10.14740/gr1280
Mittal, C., Dang, D., Stoffel, E., Menees, S., Scott, F. I., Ahnen, D., & Patel, S. G. (2020). Underutilization of lynch syndrome screening at two large Veterans Affairs medical centers. Digestive Diseases and Sciences, 65(11), 3305–3315. https://doi.org/10.1007/s10620-020-06340-0
Napolitano, M. A., Skancke, M., Walters, J., Michel, L., Randall, J. A., Brody, F. J., & Duncan, J. E. (2020). Outcomes and trends in colorectal surgery in U.S. veterans: A 10-year experience at a tertiary Veterans Affairs medical center. Journal of Laparoendoscopic & Advanced Surgical Techniques, 30(4), 378–382. https://doi.org/10.1089/lap.2019.0739
Esophageal
Hammad, T. A., Thrift, A. P., El-Serag, H. B., & Husain, N. S. (2018). Screening and surveillance for Barrett’s Esophagus in veterans subsequently diagnosed with esophageal adenocarcinoma. Gastroenterology, 154(6, Supplement 1), S-908. https://doi.org/10.1016/S0016-5085(18)33055-5
Irritable Bowels
Brenner, L. A., Forster, J. E., Stearns-Yoder, K. A., Stamper, C. E., Hoisington, A. J., Brostow, D. P., Mealer, M., Wortzel, H. S., Postolache, T. T., & Lowry, C. A. (2020). Evaluation of an immunomodulatory probiotic intervention for veterans with co-occurring mild traumatic brain injury and posttraumatic stress disorder: A pilot study. Frontiers in Neurology, 11. https://doi.org/10.3389/fneur.2020.01015
Cohen-Mekelburg, S., Saini, S. D., Krein, S. L., Hofer, T. P., Wallace, B. I., Hollingsworth, J. M., Bynum, J. P. W., Wiitala, W., Burns, J., Higgins, P. D. R., & Waljee, A. K. (2020). Association of continuity of care with outcomes in US veterans with inflammatory bowel disease. JAMA Network Open, 3(9), e2015899–e2015899. https://doi.org/10.1001/jamanetworkopen.2020.15899
Gandle, C., & Hou, J. K. (2019). Malignancy risk in veteran patients with inflammatory bowel disease: A retrospective cohort study. Gastroenterology, 156(3), S48. https://doi.org/10.1053/j.gastro.2019.01.128
Khan, N., Patel, D., Xie, D., Lewis, J., Trivedi, C., & Yang, Y.-X. (2020). Impact of anti-tumor necrosis factor and Thiopurine medications on the development of COVID-19 in patients with inflammatory bowel disease: A nationwide Veterans Administration cohort study. Gastroenterology, 159(4), 1545-1546.e1. https://doi.org/10.1053/j.gastro.2020.05.065
Khan, N., Patel, D., Xie, D., Pernes, T., Lewis, J., & Yang, Y.-X. (2020). Adherence of infusible biologics during the time of COVID-19 among patients with inflammatory bowel disease: A nationwide veterans affairs cohort study. Gastroenterology, 159(4), 1592-1594.e1. https://doi.org/10.1053/j.gastro.2020.06.044
Malhotra, A., Phatharacharukul, P., & Thongprayoon, C. (2018). Risk factors for 90-day readmission in veterans with inflammatory bowel disease: Does post-discharge follow-up matter? Military Medical Research, 5(1), 5. https://doi.org/10.1186/s40779-018-0153-x
Meghana, V., Michelle, R., David, B., Samuel, S., Shreya, N., Philip, F., … Susan, G. (2018). Vaccinate the veterans! Immunization rates in veterans with inflammatory bowel disease at the James A. Haley Veterans Hospital. American Journal of Gastroenterology, 113, S10.
Thakur, E. R., Sansgiry, S., Kramer, J. R., Waljee, A. K., Gaidos, J. K., Feagins, L. A., Govani, S. M., Dindo, L., El-Serag, H. B., & Hou, J. K. (2020). The incidence and prevalence of anxiety, depression, and post-traumatic stress disorder in a national cohort of US veterans with inflammatory bowel disease. Inflammatory Bowel Diseases, 26(9), 1423–1428. https://doi.org/10.1093/ibd/izz280
Tuteja, A. K., Talley, N. J., Stoddard, G. J., & Verne, G. N. (2019). Double-blind placebo-controlled study of rifaximin and lactulose hydrogen breath test in Gulf War veterans with irritable bowel syndrome. Digestive Diseases and Sciences, 64(3), 838–845. https://doi.org/10.1007/s10620-018-5344-5
Valluru, N., Kang, L., & Gaidos, J. K. J. (2018). Health maintenance documentation improves for veterans with IBD using a template in the computerized patient record system. Digestive Diseases and Sciences, 63(7), 1782–1786. https://doi.org/10.1007/s10620-018-5093-5
Liver Disease
Backus, L. I., Belperio, P. S., Shahoumian, T. A., & Mole, L. A. (2019). Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease. Hepatology, 69(2), 487–497. https://doi.org/10.1002/hep.29408
Dunn, S. H., Rogal, S. S., Maier, M. M., Chartier, M., Morgan, T. R., & Beste, L. A. (2019). Access to comprehensive services for advanced liver disease in the Veterans Health Administration. Digestive Diseases and Sciences, 64(12), 3471–3479. https://doi.org/10.1007/s10620-019-05785-2
Esmaeili, A., Yu, W., Cucciare, M. A., Combs, A. S., Joshi, G., & Humphreys, K. (2020). Budget impact analysis of a computer-delivered brief alcohol intervention in Veterans Affairs (VA) liver clinics: A randomized controlled trial. Alcoholism Treatment Quarterly, 38(4), 515–531. https://doi.org/10.1080/07347324.2020.1760755
Patel, Y. A., Gifford, E. J., Glass, L. M., Turner, M. J., Han, B., Moylan, C. A., … Hunt, C. M. (2018). Identifying nonalcoholic fatty liver disease advanced fibrosis in the Veterans Health Administration. Digestive Diseases and Sciences, 63(9), 2259–2266. https://doi.org/10.1007/s10620-018-5123-3
Rogal, S. S., Yakovchenko, V., Gonzalez, R., Park, A., Lamorte, C., Gibson, S. P., Chartier, M., Ross, D., Comstock, E., Bajaj, J. S., & Morgan, T. R. (2020). Characterizing patient-reported outcomes in veterans with cirrhosis. Plos One, 15(9), e0238712. https://doi.org/10.1371/journal.pone.0238712
Serper, M., Vujkovic, M., Kaplan, D. E., Carr, R. M., Lee, K. M., Shao, Q., Miller, D. R., Reaven, P. D., Phillips, L. S., O’Donnell, C. J., Meigs, J. B., Wilson, P. W. F., Vickers-Smith, R., Kranzler, H. R., Justice, A. C., Gaziano, J. M., Muralidhar, S., Pyarajan, S., DuVall, S. L., Program, on behalf of the V. M. V. (2020). Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the Million Veteran Program. Plos One, 15(8), e0237430. https://doi.org/10.1371/journal.pone.0237430
Shetty, A., & Syn, W.-K. (2019). Health and economic burden of nonalcoholic fatty liver disease in the United States and its impact on veterans. Federal Practitioner, 36(1), 14–19.
Su, G. L., Glass, L., Tapper, E. B., Van, T., Waljee, A. K., & Sales, A. E. (2018). Virtual consultations through the Veterans Administration SCAN-ECHO project improves survival for veterans with liver disease. Hepatology, 68(6), 2317–2324. https://doi.org/10.1002/hep.30074